The authors describe a rare case in a 40-year old patient of a pancreatic-pleural-pulmonary fistula. The patient had been treated six years previously on account of very painful relapsing chronic pancreatitis. After establishment of the diagnosis, confirmed by ERCP, the condition was successfully resolved by laterolateral derivation.
The authors describe a rare case of pancreatopleural fistula in a 42-year-old patient as a complication of a post-traumatic pseudocyst of the pancreas resistant to repeated conservative treatment. After establishment of a pancreatojejunal anastomosis side-to-side with an excluded jejunal loop and ligature of the fistula, regression of the pleural effusion and healing was recorded.
Research Articles| October 28 2008 Contribution to the Pathogenesis of Ventricular Fibrillation: the Pre-Fibrillation Period Subject Area: Cardiovascular System M. Takáč; M. Takáč From the Medical Clinic (Director: Prof. F. Pór) and the Surgical Clinic (Director: Prof. J. Kňazovický) Medical Faculty of the P. J. Šafárik Univerzity, Košice Search for other works by this author on: This Site PubMed Google Scholar J. Rozložník; J. Rozložník From the Medical Clinic (Director: Prof. F. Pór) and the Surgical Clinic (Director: Prof. J. Kňazovický) Medical Faculty of the P. J. Šafárik Univerzity, Košice Search for other works by this author on: This Site PubMed Google Scholar E. Matejíček; E. Matejíček From the Medical Clinic (Director: Prof. F. Pór) and the Surgical Clinic (Director: Prof. J. Kňazovický) Medical Faculty of the P. J. Šafárik Univerzity, Košice Search for other works by this author on: This Site PubMed Google Scholar M. Takácová; M. Takácová From the Medical Clinic (Director: Prof. F. Pór) and the Surgical Clinic (Director: Prof. J. Kňazovický) Medical Faculty of the P. J. Šafárik Univerzity, Košice Search for other works by this author on: This Site PubMed Google Scholar E. Milichovský E. Milichovský From the Medical Clinic (Director: Prof. F. Pór) and the Surgical Clinic (Director: Prof. J. Kňazovický) Medical Faculty of the P. J. Šafárik Univerzity, Košice Search for other works by this author on: This Site PubMed Google Scholar Cardiologia (1964) 45 (5): 276–287. https://doi.org/10.1159/000168117 Article history Published Online: October 28 2008 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation M. Takáč, J. Rozložník, E. Matejíček, M. Takácová, E. Milichovský; Contribution to the Pathogenesis of Ventricular Fibrillation: the Pre-Fibrillation Period. Cardiologia 1 May 1964; 45 (5): 276–287. https://doi.org/10.1159/000168117 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsCardiologia Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. 1964Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.